CN104524109A - 一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 - Google Patents
一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 Download PDFInfo
- Publication number
- CN104524109A CN104524109A CN201410842985.2A CN201410842985A CN104524109A CN 104524109 A CN104524109 A CN 104524109A CN 201410842985 A CN201410842985 A CN 201410842985A CN 104524109 A CN104524109 A CN 104524109A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- kidney
- semen
- yang deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title claims abstract description 24
- 208000031975 Yang Deficiency Diseases 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 20
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract description 6
- 229940079593 drug Drugs 0.000 title description 9
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims description 64
- 238000011282 treatment Methods 0.000 claims description 47
- 241000756943 Codonopsis Species 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 238000007598 dipping method Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- -1 boil 1.5 ~ 2 hours Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 32
- 208000004880 Polyuria Diseases 0.000 abstract description 14
- 230000035619 diuresis Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 230000001939 inductive effect Effects 0.000 abstract description 10
- 206010030113 Oedema Diseases 0.000 abstract description 7
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000514824 Cyathula officinalis Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 241001619454 Wolfiporia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000003973 paint Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 14
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 210000002307 prostate Anatomy 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000027939 micturition Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 7
- 206010046555 Urinary retention Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 206010013990 dysuria Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000012886 Vertigo Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 231100000889 vertigo Toxicity 0.000 description 4
- 208000008967 Enuresis Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 206010029446 nocturia Diseases 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010052901 Terminal dribbling Diseases 0.000 description 1
- 206010046542 Urinary hesitation Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗肾阳虚衰型良性前列腺增生症的药物,制成该药物有效成分的原料组成为:党参、菟丝子、山茱萸、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝、王不留行,具有补肾益气、滋阴补阳、利水消肿之功效,可有效地减轻病者负担和痛苦,能够达到标本兼治的目的,对肾阳虚衰型良性前列腺增生效果显著。本发明还提供了该药物的制备方法,可制成多种口服剂型,服用方便。
Description
技术领域
本发明属于中药领域,具体涉及一种治疗肾阳虚衰型良性前列腺增生症的药物及其制备方法。
背景技术
良性前列腺增生症,民间称前列腺肥大,中医学无此病名,按其症状当属于中医学中的“癃闭”范畴。良性前列腺增生症是老年男性常见病之一,由于它在泌尿系所造成的梗阻,影响排尿,直接威胁肾功能,对患者的生活与健康带来严重的危害。
从西医角度看,良性前列腺增生症的病因目前尚不完全清楚,估计与老年人性激素平衡失调有关。从中医角度看,良性前列腺增生症“癃闭”虽然病标在膀胱,病本却在肾脏。膀胱的气化功能,取决于肾气的盛衰,肾气有助膀胱气化津液和主宰膀胱开阖以约束尿液的作用。肾气充实,固摄有权,膀胱气化有力,开阖有度,能够维持水液的正常代谢。如果肾气不充,则膀胱气化无力,开阖失度,水道不畅,出现尿频,小便不利等症状。
老年男性之所以容易患此病,原因在于人到老年之后,肾气自衰,阳气不足,气不摄纳。特别是多数老年病人往往兼有其他慢性病,年老体衰,久病体虚,更易导致肾气虚弱。
肾阳虚衰型良性前列腺增生由于肾阳虚衰,则气化无力,气化无力,则小便不利,滴沥不净,甚者尿闭。肾阳不充,气化不及膀胱,则腰以下有冷感。肾阳虚,则舌淡,脉虚弱,腰膝无力。肾开窍于耳,老年人肾气衰弱,故常伴有听力减退或耳聋。根据“治病必求其本”的原则,应采取补益肾气、温补肾阳的治法。
发明内容
发明人依据多年的从医经验以及肾阳虚衰型良性前列腺增生症的病因病机及其治法治则,提供了一种治疗肾阳虚衰型良性前列腺增生症的药物,制成所述药物有效成分的原料组成及重量份数为:党参10-16份、菟丝子15-20份、山茱萸9-13份、枸杞子20-26份、山药8-13份、车前子22-26份、蒲公英16-21份、白术9-15份、茯苓11-16份、川牛膝8-13份、王不留行5-9份。
优选地,上述所述治疗肾阳虚衰型良性前列腺增生症的药物,其原料组成及重量份数为:党参14份、菟丝子17份、山茱萸10份、枸杞子25份、山药11份、车前子25份、蒲公英20份、白术12份、茯苓13份、川牛膝10份、王不留行8份。
解方:方中菟丝子、枸杞子、山茱萸滋补肝肾,菟丝子性温偏于助阳,枸杞子性平偏于补阴,山茱萸酸涩能收,三药配伍既补肾阳,又补肾阴,以奏阴中求阳,滋补肝肾力强,为君药。党参补中益气、健脾益肺,白术健脾益气、燥湿利水,山药补脾养胃,生津益肺,补肾涩精,茯苓利水渗湿,四药共用健脾益气,燥湿利水;车前子、蒲公英清热利尿,渗湿通淋,共为臣药,与君药共奏温阳利水,标本兼治。王不留行活血通经,蒲公英消肿散结,川牛膝逐瘀通经、利尿通淋、阴药下行,配合臣药利水消肿之效佳,为佐使药。诸药合而为之,具有补肾益气、滋阴补阳、利水消肿之功效,对肾阳虚衰型良性前列腺增生效果显著。
一种治疗肾阳虚衰型良性前列腺增生症的药物的制备方法,包括以下工艺步骤:
(1)将菟丝子、山茱萸洗净,浸入4~6倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为稠膏,备用;
(2)将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入8~10倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入6~8倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成稠膏,备用;
(3)将王不留行进行粉碎处理,研末,过180目细粉,备用;
(4)将上述步骤(1)~(3)所制得的稠膏以及细粉混合,按中药制剂常规工艺制成口服剂型,即得本发明所述的治疗肾阳虚衰型良性前列腺增生症的药物。
上述所述口服剂型可为片剂、胶囊剂、颗粒剂等。
本发明所用中药的药性如下:
党参:甘,平。归脾、肺经。功能主治:补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。
菟丝子:甘,温。归肝、肾、脾经。功能主治:滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精,尿有余沥,遗尿尿频,腰膝酸软,目昏耳鸣,肾虚胎漏,胎动不安,脾肾虚泻;外治白癜风。
山茱萸:酸、涩,微温。归肝、肾经。功能主治:补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱。内热消渴。
枸杞子:甘,平。归肝、肾经。功能主治:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
山药:甘,平。归脾、肺、肾经。功能主治:补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。
车前子:甘,微寒。归肝、肾、肺、小肠经。功能主治:清热利尿,渗湿通淋,明目,祛痰。用于水肿胀满,热淋涩痛,暑湿泄泻,目赤肿痛,痰热咳嗽。
白术:苦、甘,温。归脾、胃经。功能主治:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。
茯苓:甘、淡,平。归心、肺、脾、肾经。功能主治:利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
川牛膝:甘、微苦,平。归肝、肾经。功能主治:逐瘀通经,通利关节,利尿通淋。用于经闭症瘕,胞衣不下,关节痹痛,足痿筋挛,尿血血淋,跌扑损伤。
蒲公英:苦、甘,寒。归肝、胃经。功能主治:清热解毒,消肿散结,利尿通淋。用于疔疮肿毒,乳痈,瘰疠,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。
王不留行:苦,平。归肝、胃经。功能主治:活血通经,下乳消肿。用于乳汁不下,经闭,痛经,乳痈肿痛。
本发明药物所选药材配伍相宜,符合中医药学和现代医药学理论,并具有补肾益气、滋阴补阳、利水消肿之功效,对治疗肾阳虚衰型良性前列腺增生症具有显著的疗效,服用方便,治愈后不复发,安全无毒副作用,可有效地减轻病者负担和痛苦,能够达到标本兼治的目的,成本低廉,值得临床上广泛推广应用。
具体实施方式
下面结合具体实施方式及试验例对本发明作进一步的详细描述。但不应将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明内容所实现的技术均属于本发明的范围。
实施例1
处方:原料组成及重量份数为:党参14份、菟丝子17份、山茱萸10份、枸杞子25份、山药11份、车前子25份、蒲公英20份、白术12份、茯苓13份、川牛膝10份、王不留行8份。
制备方法:将菟丝子、山茱萸洗净,浸入5倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为60℃下相对密度为1.15的稠膏,备用;将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入9倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入7倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成60℃下相对密度为1.07的稠膏,备用;将王不留行进行粉碎处理,研末,过180目细粉,备用;将上述步骤所制得的稠膏以及细粉混合,加入适量辅料,按中药制剂常规工艺制成胶囊。
实施例2
处方:原料组成及重量份数为:党参10份、菟丝子15份、山茱萸9份、枸杞子20份、山药8份、车前子22份、蒲公英16份、白术9份、茯苓11份、川牛膝8份、王不留行5份。
制备方法:将菟丝子、山茱萸洗净,浸入4倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为60℃下相对密度为1.10的稠膏,备用;将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入8倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入6倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成60℃下相对密度为1.03的稠膏,备用;将王不留行进行粉碎处理,研末,过180目细粉,备用;将上述步骤所制得的稠膏以及细粉混合,加入适量辅料,按中药制剂常规工艺制成胶囊。
实施例3
处方:原料组成及重量份数为:党参16份、菟丝子20份、山茱萸13份、枸杞子26份、山药13份、车前子26份、蒲公英21份、白术15份、茯苓16份、川牛膝13份、王不留行9份。
制备方法:将菟丝子、山茱萸洗净,浸入6倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为60℃下相对密度为1.20的稠膏,备用;将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入10倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入8倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成60℃下相对密度为1.13的稠膏,备用;将王不留行进行粉碎处理,研末,过180目细粉,备用;将上述步骤所制得的稠膏以及细粉混合,加入适量辅料,按中药制剂常规工艺制成胶囊。
实施例4
处方:原料组成及重量份数为:党参13份、菟丝子15份、山茱萸13份、枸杞子25份、山药8份、车前子22份、蒲公英16份、白术9份、茯苓14份、川牛膝10份、王不留行7份。
制备方法:将菟丝子、山茱萸洗净,浸入5倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为60℃下相对密度为1.17的稠膏,备用;将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入9倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入6下相对密度为1.08的稠膏,备用;将王不留行进行粉碎处理,研末,过180目细粉,备用;将上述步骤所制得的稠膏以及细粉混合,加入适量辅料,按中药制剂常规工艺制成片剂。
实施例5
处方:原料组成及重量份数为:党参14份、菟丝子20份、山茱萸12份、枸杞子26份、山药13份、车前子22份、蒲公英16份、白术14份、茯苓15份、川牛膝8份、王不留行9份。
制备方法:将菟丝子、山茱萸洗净,浸入6倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为60℃下相对密度为1.17的稠膏,备用;将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入8倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入8倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成60℃下相对密度为1.10的稠膏,备用;将王不留行进行粉碎处理,研末,过180目细粉,备用;将上述步骤所制得的稠膏以及细粉混合,加入适量辅料,按中药制剂常规工艺制成颗粒剂。
实施例6
处方:原料组成及重量份数为:党参16份、菟丝子15份、山茱萸9份、枸杞子26份、山药11份、车前子26份、蒲公英18份、白术15份、茯苓11份、川牛膝10份、王不留行7份。
制备方法:参照实施例1进行。
实施例7
处方:原料组成及重量份数为:党参15份、菟丝子15份、山茱萸10份、枸杞子25份、山药12份、车前子25份、蒲公英20份、白术12份、茯苓13份、川牛膝11份、王不留行8份。
制备方法:参照实施例1进行。
以下通过临床试验例来进一步说明本发明。
1.一般资料:选择2011年9月-2012年6月在我院中医门诊就诊的80例BPH(肾阳虚衰型)患者为研究对象,按照随机数字表法随机分为治疗组和对照组,每组30例。治疗组患者年龄为(67.5±4.3)岁,病程为(5.6±1.2)年,治疗前国际前列腺症状评分(I-PSS)为(20.1±6.3)分;对照组患者年龄为(69.1±4.5)岁,病程为(5.8±1.5)年,治疗前I-PSS为(20.4±5.7)分。两组患者一般资料差异无统计学意义(P>0.05),具有可比性。
2.诊断及纳入标准:参照陈贵廷《最新国内外疾病诊断标准》拟定。即:50岁以上的男性有进行性排尿困难;排尿后,直肠指诊可触到增大的前列腺表面光滑、质韧、有弹性、中央沟消失或隆起;B型超声检查:检查测量前列腺体积及其内部结构,其中前列腺体积>20mL;中医辨证为肾阳虚衰型,症见:小便不爽,或频数,夜尿频多、量少,尿末滴沥不尽,或排出无力,或遗尿不能自禁,神疲懒言,会阴或腰部冷痛,伴有阳萎、遗精,舌淡、苔白或白腻,脉沉细。排除其它良性、恶性病变。
3.治疗及护理方法:
治疗组:给予本发明实施例1制备的胶囊剂,每粒0.3g,每次3粒,一日两次;对照组:给予金匮肾气丸(北京同仁堂股份有限公司同仁堂制药厂)一次20-25丸,一日两次;两组均忌生、冷、粘、硬(如:冷饮,粘糕)、烟酒,辛辣等食物,4周为一疗程,两个疗程后进行疗效评价。
4.观察项目与检测方法:
4.1观察治疗前后中医症状(包括夜尿次数、排尿困难、尿后滴沥)改善情况。
4.2观察治疗前后IPSS总分、残余尿量及前列腺体积变化。
4.3安全性评价分别于用药前后进行肝、肾功能测定,并及时记录各种不良反应。
5.疗效标准治愈:症状消失,排尿通畅,残余尿<20ml,停药以后无复发,前列腺B超检查示腺体大小、质地、形态均恢复正常,I-PSS总分<7分;有效:排尿症状明显改善,但残余尿仍在20-60ml之间。前列腺B超检查示前列腺大小、形态、质地未恢复正常,但较治疗前有好转,I-PSS总分7-13分;无效:症状以及前列腺B超检查腺体大小、质地、形态均无改善,I-PSS总分无变化。
6.统计学方法:采用SPSS15.0统计分析软件进行计算,组内前后差异采用配对t检验比较,等级资料的比较采用Ridit分析,以P<0.05为有统计学意义。
7.结果:
7.1两组中医症状改善情况比较:两组治疗后夜尿次数、排尿困难、尿后滴沥与治疗前比较均有改善,差异均有统计学意义(P<0.05),治疗后两组间比较,差异亦有统计学意义(P<0.05),见表1。
表1中医症状改善情况比较,分
注:与本组治疗前比较*P<0.05,与对照组治疗后比较#P<0.05。
7.2两组治疗前后I-PSS总分、残余尿及前列腺体积比较:与治疗前比较,两组治疗后I-PSS评分、残余尿差异均有统计学意义(P<0.05),治疗组与对照组治疗后比较,差异也有统计学意义(P<0.05);与治疗前比较,前列腺体积差异有统计学意义(P<0.05),治疗组与对照组治疗后比较,差异无有统计学意义(P>0.05),见表2。
表2两组治疗前后I-PSS总分、残余尿及前列腺体积比较
注:与本组治疗前比较*P<0.05,与对照组治疗后比较#P<0.05。
7.3两组中医证候疗效比较:治疗组:显效25例;有效11;无效4;总有效率为90.0%(36/40);对照组:显效14例;有效9;无效17;总有效率57.5%(23/40)。两组比较,差异有统计学意义(P<0.05)。治疗组疗效明显优于对照组。
7.4药物不良反应:本次观察过程中,两治疗组均未见肝、肾功能明显异常,两组治疗期间及门诊随访未发现有急性尿储留发生。治疗组有2例,对照组有3例诉胃部不适、口渴等,均未影响患者继续服药,亦未做纠正治疗。
小结:通过本次临床观察试验,我们可以发现本发明中药制剂与现有药物或现有药物的组合相比,对治疗肾阳虚衰型良性前列腺增生,具有明显的优势和效果,值得推广应用。
Claims (5)
1.一种治疗肾阳虚衰型良性前列腺增生症的药物,其特征在于制成所述药物有效成分的原料组成为:党参、菟丝子、山茱萸、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝、王不留行。
2.如权利要求1所述的治疗肾阳虚衰型良性前列腺增生症的药物,其特征在于制成所述药物有效成分的原料组成及重量份数为:党参10-16份、菟丝子15-20份、山茱萸9-13份、枸杞子20-26份、山药8-13份、车前子22-26份、蒲公英16-21份、白术9-15份、茯苓11-16份、川牛膝8-13份、王不留行5-9份。
3.如权利要求2所述的治疗肾阳虚衰型良性前列腺增生症的药物,其特征在于制成所述药物有效成分的原料组成及重量份数优选为:党参14份、菟丝子17份、山茱萸10份、枸杞子25份、山药11份、车前子25份、蒲公英20份、白术12份、茯苓13份、川牛膝10份、王不留行8份。
4.如权利要求1-3所述的治疗肾阳虚衰型良性前列腺增生症的药物,其特征在于其制备方法包括以下步骤:
(1)将菟丝子、山茱萸洗净,浸入4~6倍量的80%的乙醇溶液浸泡1~2小时,加热提取2小时,回收乙醇,滤过,得滤液,浓缩为稠膏,备用;
(2)将党参、枸杞子、山药、车前子、蒲公英、白术、茯苓、川牛膝洗净,加入8~10倍量的蒸馏水,浸泡3~4小时后,煮沸2~3小时,提取;再次加入6~8倍量蒸馏水,煮沸1.5~2小时,提取;合并提取液,过滤,得滤液,浓缩成稠膏,备用;
(3)将王不留行进行粉碎处理,研末,过180目细粉,备用;
(4)将上述步骤(1)~(3)所制得的稠膏以及细粉混合,按中药制剂常规工艺制成口服剂型,即得本发明所述的治疗肾阳虚衰型良性前列腺增生症的药物。
5.如权利要求4所述的治疗肾阳虚衰型良性前列腺增生症的药物,其特征在于所述的口服剂型优选为片剂、胶囊剂、颗粒剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410842985.2A CN104524109A (zh) | 2014-12-30 | 2014-12-30 | 一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410842985.2A CN104524109A (zh) | 2014-12-30 | 2014-12-30 | 一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104524109A true CN104524109A (zh) | 2015-04-22 |
Family
ID=52839865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410842985.2A Pending CN104524109A (zh) | 2014-12-30 | 2014-12-30 | 一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524109A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308166A (zh) * | 2017-07-11 | 2017-11-03 | 东新皓特(北京)生化科技有限公司 | 河豚毒素在制备治疗前列腺病症药物组合物中的应用、药物组合物及制备方法 |
CN110101827A (zh) * | 2019-03-08 | 2019-08-09 | 卢建康 | 一种治疗前列腺增生的中药制剂 |
CN110585306A (zh) * | 2019-09-26 | 2019-12-20 | 孙鸿志 | 一种治疗良性前列腺增生症的药物组合及其制备方法 |
CN113679757A (zh) * | 2021-09-08 | 2021-11-23 | 上海交通大学医学院附属第九人民医院 | 一种改善膀胱收缩力的药物组合物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518603A (zh) * | 2008-02-28 | 2009-09-02 | 北京中泰天和科技有限公司 | 一种治疗前列腺增生的中药组合及其制备方法 |
CN102233107A (zh) * | 2010-04-27 | 2011-11-09 | 刘国昌 | 一种治疗前列腺炎及前列腺增生的中成药 |
-
2014
- 2014-12-30 CN CN201410842985.2A patent/CN104524109A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518603A (zh) * | 2008-02-28 | 2009-09-02 | 北京中泰天和科技有限公司 | 一种治疗前列腺增生的中药组合及其制备方法 |
CN102233107A (zh) * | 2010-04-27 | 2011-11-09 | 刘国昌 | 一种治疗前列腺炎及前列腺增生的中成药 |
Non-Patent Citations (4)
Title |
---|
刘文华等: "《喜乐活到天年》", 31 January 2012, 辽宁科学技术出版社 * |
武传贵等: "补肾化瘀通淋法治疗前列腺增生症84例", 《辽宁中医杂志》 * |
瓦陈庆: "中医辨证治疗前列腺肥大45例", 《河北中医》 * |
蔡淦: "《中医内科大全》", 31 May 2009, 中医古籍出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308166A (zh) * | 2017-07-11 | 2017-11-03 | 东新皓特(北京)生化科技有限公司 | 河豚毒素在制备治疗前列腺病症药物组合物中的应用、药物组合物及制备方法 |
CN110101827A (zh) * | 2019-03-08 | 2019-08-09 | 卢建康 | 一种治疗前列腺增生的中药制剂 |
CN110585306A (zh) * | 2019-09-26 | 2019-12-20 | 孙鸿志 | 一种治疗良性前列腺增生症的药物组合及其制备方法 |
CN113679757A (zh) * | 2021-09-08 | 2021-11-23 | 上海交通大学医学院附属第九人民医院 | 一种改善膀胱收缩力的药物组合物及其应用 |
CN113679757B (zh) * | 2021-09-08 | 2022-05-31 | 上海交通大学医学院附属第九人民医院 | 一种改善膀胱收缩力的药物组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101926961A (zh) | 一种内服治疗盆腔炎的中药组合物 | |
CN105327205A (zh) | 一种治疗甲状腺癌的中药制剂 | |
CN104189789A (zh) | 一种治疗急性传染性黄疸型肝炎的中药组合物 | |
CN104524109A (zh) | 一种治疗肾阳虚衰型良性前列腺增生症的药物及制备方法 | |
CN101401918B (zh) | 一种治疗脂肪肝的中药组合物 | |
CN104225215A (zh) | 一种治疗失眠的中药 | |
CN101879288A (zh) | 一种治疗肾积水的中药方剂 | |
CN105055849A (zh) | 滋阴养肾的中药提取物及其制备方法和应用 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN100534522C (zh) | 一种内服治疗慢性盆腔炎的中药散剂 | |
CN103341092A (zh) | 一种治疗萎缩性阴道炎的散剂制备方法 | |
CN103432270B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN102274445A (zh) | 桂枝三棱消瘤丸 | |
WO2019104931A1 (zh) | 一种治疗白血病的中药组合物及其制备方法 | |
CN104383268A (zh) | 一种治疗高血压的中药组合物 | |
CN104288296A (zh) | 一种治疗胆结石的中药组合物 | |
CN104189764A (zh) | 一种治疗介入术后发热的中药制剂及其制备方法 | |
CN105327171A (zh) | 一种治疗乳腺炎的中药冲剂及其制备方法 | |
CN105362647A (zh) | 一种制备治疗妇科出血症的药物组合物的方法 | |
CN105816813A (zh) | 一种治疗乳腺癌的药物组合物及其制备方法和应用 | |
CN104922499A (zh) | 一种治疗肝炎的中药 | |
CN104491316B (zh) | 一种治疗中气不足型前列腺增生症的中药制剂 | |
CN104083548A (zh) | 一种治疗卵巢囊肿的中药组合物及其制备方法 | |
CN103623334A (zh) | 一种治疗肾炎的中药组合物 | |
CN104274720A (zh) | 一种排石通淋的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150422 |
|
WD01 | Invention patent application deemed withdrawn after publication |